I’ve spent 11 years in pharma commercial operations and managed markets. If I see one more "strategic alignment" slide deck that how to influence formulary development treats every conference like a universal sales opportunity, I’m going to scream. Most teams treat congress planning like a field trip rather than a tactical deployment.
You aren’t at AMCP to collect pens. You aren’t at THMA to talk to other pharma reps. You are there to defend value, navigate formulary hurdles, and understand the shifting HTA landscape. If your cross-functional team doesn't have a specific mission, you’re just paying for expensive hotel rooms.
The Essential Roster: Who Actually Needs to Go?
Stop sending your entire field force to every meeting. It’s a waste of budget and it confuses the customers. If you are building a squad for a major congress, you need to be surgical. Your **market access HEOR medical affairs** core should look like this:
- The Payer Lead: Someone who knows the specific national and regional plans attending the event. If they don’t know who the Pharmacy Director is for the top three regional plans, they shouldn't be in the room. The HEOR Lead: They aren’t there to present a poster; they are there to field technical questions about the data that support the value proposition. The Pricing Strategy Team Member: This person needs to understand the "affordability" conversation. When a hospital CFO asks about the delta between WAC and ASP, your rep shouldn't be checking with Home Office. The Patient Access Operations Specialist: They solve the "how." They handle the logistics of getting the drug from the hub to the patient’s hands.
Venue Intelligence: Matching the Team to the Audience
Not all conferences are built for the same conversations. If you are sending your generalist sales reps to a high-level executive roundtable, you’re sabotaging your own brand.
Conference Primary Goal The "Who You Actually Meet" Note AMCP Managed Care Strategy P&T Committee members, Pharmacy Directors, and Pharmacy Benefit Managers (PBMs). This is your deep-dive space. THMA Health System Adoption C-suite of large health systems. These people care about total cost of care, not just individual drug spend. ACCC Formulary Execution Oncology program directors, hospital administrators, and specialized pharmacy staff. Practical, real-world workflow issues.For context, if you're looking at a website for these organizations and you're getting hung up on the Cookie Law Info plugin UI elements or irrelevant site-level tracking notices, you've already lost the plot. Focus on the attendee list and the specific sessions. If you’re distracted by the digital wrapper, you aren’t looking at the real-world strategy.
Market Access vs. Prescriber Reach
There is a massive divide between these two functions, and it gets worse at conferences. A prescriber wants to know about efficacy and safety. A market access leader wants to know about the net price, the rebate, and the utilization management criteria.
When you put both teams in the same booth, the messaging becomes diluted. Prescribers get bored by "pricing strategy" talk, and payers get annoyed by "clinical trial" sales pitches. Your cross-functional access team needs a "Code of Conduct" for the booth: If a provider walks up, the Market Access team steps back. If a Payer/Health System Exec pharma market access conferences 2026 approaches, the sales rep defers to the Access Lead immediately.
Pricing, Affordability, and HTA Pressure
The conversation around HTA (Health Technology Assessment) is moving faster than our internal review processes. When you attend an ACCC or AMCP event, the pressure isn't just about whether the drug works—it's about whether the system can afford to keep it in the formulary next year.
Your team needs to be equipped with digital tools in evidence generation and reimbursement. Don't just give them a glossy brochure. Give them an iPad with a calculator that shows the budget impact of the drug versus the current standard of care. If they can’t run the numbers on the fly, they aren't helping. "Great networking" is a vague claim that means nothing. "We had five substantive conversations regarding utilization management for our new launch" is actual progress.
What Would I Do Differently on Monday?
I always ask this before the plane even lands. If you went to a conference and you can’t answer this question on Monday morning, you failed.
Review the "Who You Actually Met" Spreadsheet: I keep a running log. Did we meet the person we intended to? Did we gain a new insight into a formulary barrier that wasn't previously on our radar? Evaluate the Tools: Did the digital evidence tools actually work? If the internet was spotty at the conference center and your tool relied on a cloud-based server, note it. Fix the offline mode for next time. The "Monday Morning" Debrief: Hold a meeting where the only goal is to discuss *specific* blockers. Don't ask, "How did it go?" Ask, "What specific policy change did we hear about that alters our contracting strategy for Q3?"The Trap of Buzzwords
I’ve heard enough about "synergy" to last a lifetime. In market access, there is no synergy—there is only work. You are dealing with complicated, bureaucratic, and often hostile environments. You don't need a "streamlined" approach; you need a precise one. You need to know which hospital system is moving to a risk-based contract and which PBM is tightening their prior authorization requirements.
Stop worrying about how "seamless" your team looks. Worry about whether they can hold their own in a conversation about medical necessity criteria. If your team is more worried about their LinkedIn presence at the booth than they are about the specific challenges of a regional formulary, they aren't part of the access team. They’re part of the noise.
Tactical Execution for the Next Congress
Before your next big meeting, sit down and map out exactly what you want to achieve. If you are going to AMCP, your goal should be to identify three specific payers whose UM criteria are misaligned with your data. If you are going to THMA, identify two health systems that are struggling with the integration of your therapy into their outpatient oncology workflow.
Bring the right people. Send the Pricing Strategy lead, not a general marketing manager. Send the Patient Access Operations lead, not a junior product manager. The people on the front lines of the payer contract are the only ones who can turn a "great event" into a measurable increase in market access.
And for heaven's sake, keep a spreadsheet. If it isn't tracked, it didn't happen. The "who you actually meet" notes are the most valuable asset you’ll take home. Everything else is just expensive catering and badges.